Acorda Therapeutics Inc (ACORQ)
0.85
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Acorda Therapeutics Total Assets (Quarterly): 108.52M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 108.52M |
| September 30, 2023 | 366.34M |
| June 30, 2023 | 364.70M |
| March 31, 2023 | 374.91M |
| December 31, 2022 | 395.60M |
| September 30, 2022 | 393.34M |
| June 30, 2022 | 406.31M |
| March 31, 2022 | 424.14M |
| December 31, 2021 | 455.47M |
| September 30, 2021 | 466.09M |
| June 30, 2021 | 491.50M |
| March 31, 2021 | 584.05M |
| December 31, 2020 | 632.68M |
| September 30, 2020 | 710.45M |
| June 30, 2020 | 728.21M |
| March 31, 2020 | 753.83M |
| December 31, 2019 | 799.72M |
| September 30, 2019 | 879.91M |
| June 30, 2019 | 1.197B |
| March 31, 2019 | 1.234B |
| December 31, 2018 | 1.300B |
| September 30, 2018 | 1.311B |
| June 30, 2018 | 1.251B |
| March 31, 2018 | 1.187B |
| December 31, 2017 | 1.198B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.345B |
| June 30, 2017 | 1.332B |
| March 31, 2017 | 1.320B |
| December 31, 2016 | 1.342B |
| September 30, 2016 | 1.318B |
| June 30, 2016 | 1.347B |
| March 31, 2016 | 1.212B |
| December 31, 2015 | 1.111B |
| September 30, 2015 | 1.100B |
| June 30, 2015 | 1.101B |
| March 31, 2015 | 1.099B |
| December 31, 2014 | 1.065B |
| September 30, 2014 | 972.77M |
| June 30, 2014 | 943.32M |
| March 31, 2014 | 611.89M |
| December 31, 2013 | 607.13M |
| September 30, 2013 | 586.65M |
| June 30, 2013 | 575.91M |
| March 31, 2013 | 565.42M |
| December 31, 2012 | 565.33M |
| September 30, 2012 | 410.45M |
| June 30, 2012 | 403.05M |
| March 31, 2012 | 386.05M |
| December 31, 2011 | 379.49M |
| September 30, 2011 | 351.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
108.52M
Minimum
Dec 2023
1.197B
Maximum
Jun 2019
554.38M
Average
466.09M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| BioSig Technologies Inc | 1.798M |
| Verve Therapeutics Inc | 752.69M |
| Spectral AI Inc | 12.33M |
| AIM ImmunoTech Inc | 19.38M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 266.48M |
| Shareholders Equity (Quarterly) | -157.96M |
| Debt to Equity Ratio | -1.178 |
| Current Ratio | 0.3284 |
| Net Debt Paydown Yield | 1.65% |